Impact of NIRS-guided Cardiopulmonary Resuscitation After Cardiac Arrest on Resuscitation Rate
Launched by DR. SERGE THAL · Apr 9, 2019
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a cardiac arrest from the age of 18 years (in and out-of-hospital cardiac arrest)
- Exclusion Criteria:
- • post-traumatic cardiac arrest
- • non-fitting NIRS sensor (size)
About Dr. Serge Thal
Dr. Serge Thal is an esteemed clinical trial sponsor renowned for his commitment to advancing medical research and innovation. With a robust background in clinical medicine and extensive experience in trial design and execution, Dr. Thal leads initiatives that prioritize patient safety and efficacy in therapeutic development. His organization collaborates with leading research institutions and healthcare professionals to conduct rigorous trials that adhere to the highest ethical standards. Dr. Thal’s dedication to enhancing treatment options through evidence-based research positions him as a pivotal figure in the landscape of clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mainz, Rheinland Pfalz, Germany
Patients applied
Trial Officials
Serge C Thal, MD
Principal Investigator
Department of Anesthesiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials